HEADER MEMBRANE PROTEIN 03-OCT-19 6UJV TITLE MODEL OF THE HIV-1 GP41 MEMBRANE-PROXIMAL EXTERNAL REGION, TITLE 2 TRANSMEMBRANE DOMAIN AND CYTOPLASMIC TAIL (LLP2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN GP41; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 658-786; COMPND 5 SYNONYM: ENV POLYPROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: ISOLATE 92UG024.2; SOURCE 5 GENE: ENV; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMM-LR6 KEYWDS VIRAL PROTEIN, MEMBRANE-PROXIMAL EXTERNAL REGION, TRANSMEMBRANE KEYWDS 2 DOMAIN, CYTOPLASMIC TAIL, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR A.PIAI,Q.FU,Y.CAI,F.GHANTOUS,T.XIAO,M.M.SHAIK,H.PENG,S.RITS-VOLLOCH, AUTHOR 2 Z.LIU,W.CHEN,M.S.SEAMAN,B.CHEN,J.J.CHOU REVDAT 5 15-MAY-24 6UJV 1 REMARK REVDAT 4 14-JUN-23 6UJV 1 REMARK REVDAT 3 16-MAR-22 6UJV 1 REMARK REVDAT 2 20-MAY-20 6UJV 1 JRNL REVDAT 1 13-MAY-20 6UJV 0 JRNL AUTH A.PIAI,Q.FU,Y.CAI,F.GHANTOUS,T.XIAO,M.M.SHAIK,H.PENG, JRNL AUTH 2 S.RITS-VOLLOCH,W.CHEN,M.S.SEAMAN,B.CHEN,J.J.CHOU JRNL TITL STRUCTURAL BASIS OF TRANSMEMBRANE COUPLING OF THE HIV-1 JRNL TITL 2 ENVELOPE GLYCOPROTEIN. JRNL REF NAT COMMUN V. 11 2317 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32385256 JRNL DOI 10.1038/S41467-020-16165-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Q.FU,M.M.SHAIK,Y.CAI,F.GHANTOUS,A.PIAI,H.PENG, REMARK 1 AUTH 2 S.RITS-VOLLOCH,Z.LIU,S.C.HARRISON,M.S.SEAMAN,B.CHEN,J.J.CHOU REMARK 1 TITL STRUCTURE OF THE MEMBRANE PROXIMAL EXTERNAL REGION OF HIV-1 REMARK 1 TITL 2 ENVELOPE GLYCOPROTEIN. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 115 E8892 2018 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ESSN 1091-6490 REMARK 1 PMID 30185554 REMARK 1 DOI 10.1073/PNAS.1807259115 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.DEV,D.PARK,Q.FU,J.CHEN,H.J.HA,F.GHANTOUS,T.HERRMANN, REMARK 1 AUTH 2 W.CHANG,Z.LIU,G.FREY,M.S.SEAMAN,B.CHEN,J.J.CHOU REMARK 1 TITL STRUCTURAL BASIS FOR MEMBRANE ANCHORING OF HIV-1 ENVELOPE REMARK 1 TITL 2 SPIKE. REMARK 1 REF SCIENCE V. 353 172 2016 REMARK 1 REFN ESSN 1095-9203 REMARK 1 PMID 27338706 REMARK 1 DOI 10.1126/SCIENCE.AAF7066 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6UJV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1000244734. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.7 MM [U-13C; U-15N; U-85% 2H] REMARK 210 HIV-1 GP41 TMD-CT(LLP2), 40 MM REMARK 210 MES, 40 MM DMPC, 80 MM DHPC, 90% REMARK 210 H2O/10% D2O; 0.8 MM [U-15N; U-2H] REMARK 210 HIV-1 GP41 TMD-CT(LLP2), 40 MM REMARK 210 MES, 80 MM DMPC, 80 MM DHPC, 90% REMARK 210 H2O/10% D2O; 1.0 MM [U-13C; U- REMARK 210 15N] HIV-1 GP41 TMD-CT(LLP2), 40 REMARK 210 MM MES, 80 MM DMPC, 80 MM DHPC, REMARK 210 90% H2O/10% D2O; 0.5 MM [U-15N; REMARK 210 U-2H] HIV-1 GP41 TMD-CT(LLP2), REMARK 210 40 MM MES, 40 MM DMPC, 80 MM REMARK 210 DHPC, 90% H2O/10% D2O; 0.5 MM [U- REMARK 210 15N; U-2H] HIV-1 GP41 TMD- REMARK 210 CT(LLP2), 0.5 MM [U-13C] HIV-1 REMARK 210 GP41 TMD-CT(LLP2), 40 MM MES, 40 REMARK 210 MM DMPC, 80 MM DHPC, 90% H2O/10% REMARK 210 D2O; 0.5 MM [U-15N; U-85% 2H] REMARK 210 HIV-1 GP41 TMD-CT(LLP2), 40 MM REMARK 210 MES, 40 MM DMPC, 80 MM DHPC, 90% REMARK 210 H2O/10% D2O; 0.8 MM [U-13C; U- REMARK 210 15N; U-85% 2H] HIV-1 GP41 MPER- REMARK 210 TMD, 40 MM MOPS, 50 MM DMPC, 100 REMARK 210 MM DHPC, 90% H2O/10% D2O; 0.8 MM REMARK 210 [U-15N; U-2H] HIV-1 GP41 MPER- REMARK 210 TMD, 40 MM MOPS, 50 MM DMPC, 100 REMARK 210 MM DHPC, 90% H2O/10% D2O; 0.8 MM REMARK 210 [U-13C; U-15N] HIV-1 GP41 MPER- REMARK 210 TMD, 40 MM MOPS, 50 MM DMPC, 100 REMARK 210 MM DHPC, 90% H2O/10% D2O; 0.4 MM REMARK 210 [U-15N; U-2H] HIV-1 GP41 MPER- REMARK 210 TMD, 40 MM MOPS, 50 MM DMPC, 100 REMARK 210 MM DHPC, 90% H2O/10% D2O; 0.4 MM REMARK 210 [U-15N; U-2H] HIV-1 GP41 MPER- REMARK 210 TMD, 0.4 MM [U-13C] HIV-1 GP41 REMARK 210 MPER-TMD, 40 MM MOPS, 50 MM DMPC, REMARK 210 100 MM DHPC, 90% H2O/10% D2O; REMARK 210 0.8 MM [U-15N; U-85% 2H] HIV-1 REMARK 210 GP41 MPER-TMD, 40 MM MOPS, 50 MM REMARK 210 DMPC, 85 MM DPC, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N TROSY-HSQC; 3D TROSY REMARK 210 HNCO; 3D TROSY HNCA; 3D TROSY REMARK 210 HN(CA)CO; 3D TROSY HN(CO)CA; 3D REMARK 210 TROSY HNCACB; 3D 15N-EDITED REMARK 210 NOESY-TROSY-HSQC; 2D 1H-13C HSQC; REMARK 210 3D 13C-EDITED NOESY; 3D J(CH)- REMARK 210 MODULATED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ; 800 MHZ; 900 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, CARA, XEASY, X REMARK 210 -PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 PHE A 717 REMARK 465 GLN A 718 REMARK 465 THR A 719 REMARK 465 HIS A 720 REMARK 465 LEU A 721 REMARK 465 PRO A 722 REMARK 465 THR A 723 REMARK 465 PRO A 724 REMARK 465 ARG A 725 REMARK 465 GLY A 726 REMARK 465 PRO A 727 REMARK 465 ASP A 728 REMARK 465 ARG A 729 REMARK 465 PRO A 730 REMARK 465 GLU A 731 REMARK 465 GLY A 732 REMARK 465 ILE A 733 REMARK 465 GLU A 734 REMARK 465 GLU A 735 REMARK 465 GLU A 736 REMARK 465 GLY A 737 REMARK 465 GLY A 738 REMARK 465 PHE B 717 REMARK 465 GLN B 718 REMARK 465 THR B 719 REMARK 465 HIS B 720 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 THR B 723 REMARK 465 PRO B 724 REMARK 465 ARG B 725 REMARK 465 GLY B 726 REMARK 465 PRO B 727 REMARK 465 ASP B 728 REMARK 465 ARG B 729 REMARK 465 PRO B 730 REMARK 465 GLU B 731 REMARK 465 GLY B 732 REMARK 465 ILE B 733 REMARK 465 GLU B 734 REMARK 465 GLU B 735 REMARK 465 GLU B 736 REMARK 465 GLY B 737 REMARK 465 GLY B 738 REMARK 465 PHE C 717 REMARK 465 GLN C 718 REMARK 465 THR C 719 REMARK 465 HIS C 720 REMARK 465 LEU C 721 REMARK 465 PRO C 722 REMARK 465 THR C 723 REMARK 465 PRO C 724 REMARK 465 ARG C 725 REMARK 465 GLY C 726 REMARK 465 PRO C 727 REMARK 465 ASP C 728 REMARK 465 ARG C 729 REMARK 465 PRO C 730 REMARK 465 GLU C 731 REMARK 465 GLY C 732 REMARK 465 ILE C 733 REMARK 465 GLU C 734 REMARK 465 GLU C 735 REMARK 465 GLU C 736 REMARK 465 GLY C 737 REMARK 465 GLY C 738 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 661 116.58 57.97 REMARK 500 1 ASP A 674 -61.93 -143.50 REMARK 500 1 TYR A 712 -127.73 52.18 REMARK 500 1 PRO A 714 106.62 -43.59 REMARK 500 1 LEU A 765 -87.27 101.29 REMARK 500 1 PHE A 766 -70.68 -110.80 REMARK 500 1 LEU B 661 116.24 60.92 REMARK 500 1 ASP B 674 -70.83 -140.26 REMARK 500 1 PRO B 714 113.49 -32.72 REMARK 500 1 LEU B 765 99.66 71.10 REMARK 500 1 PHE B 766 -80.94 65.89 REMARK 500 1 LEU C 661 109.15 59.02 REMARK 500 1 ASP C 674 -72.00 -146.59 REMARK 500 1 TYR C 712 -54.42 -132.90 REMARK 500 1 PRO C 714 96.34 -30.06 REMARK 500 1 LEU C 765 83.62 78.17 REMARK 500 1 PHE C 766 -81.01 60.17 REMARK 500 2 LEU A 661 106.75 59.52 REMARK 500 2 GLU A 662 -178.62 179.41 REMARK 500 2 ASP A 674 -71.06 -150.40 REMARK 500 2 TYR A 712 -171.93 71.97 REMARK 500 2 PRO A 714 92.42 -12.51 REMARK 500 2 ASP A 741 -6.79 -55.79 REMARK 500 2 LEU A 765 -60.53 77.07 REMARK 500 2 PHE A 766 -67.72 -145.96 REMARK 500 2 LEU B 661 83.47 52.29 REMARK 500 2 ASP B 674 -72.05 -148.61 REMARK 500 2 TYR B 712 -61.58 -102.49 REMARK 500 2 PRO B 714 118.59 -29.32 REMARK 500 2 ASP B 741 -9.38 -55.13 REMARK 500 2 LEU B 765 89.34 63.86 REMARK 500 2 PHE B 766 122.11 72.74 REMARK 500 2 SER B 767 164.26 57.82 REMARK 500 2 TYR B 768 64.31 -109.84 REMARK 500 2 HIS B 769 -42.51 -144.25 REMARK 500 2 ASP C 674 -59.94 -136.72 REMARK 500 2 TYR C 712 -53.44 -132.22 REMARK 500 2 PRO C 714 93.56 -31.31 REMARK 500 2 PHE C 766 -89.62 79.07 REMARK 500 3 LEU A 661 119.65 170.25 REMARK 500 3 GLU A 662 -174.16 178.06 REMARK 500 3 ASP A 674 -66.94 -123.90 REMARK 500 3 TYR A 712 -123.24 61.94 REMARK 500 3 PRO A 714 109.04 -44.59 REMARK 500 3 LEU A 765 -78.18 82.98 REMARK 500 3 PHE A 766 -70.65 -109.99 REMARK 500 3 LEU B 661 103.90 61.02 REMARK 500 3 ASP B 674 -71.33 -153.64 REMARK 500 3 TYR B 712 -65.05 -96.03 REMARK 500 3 PRO B 714 142.30 -31.63 REMARK 500 REMARK 500 THIS ENTRY HAS 297 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 5 ARG A 707 0.09 SIDE CHAIN REMARK 500 12 ARG A 747 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5JYN RELATED DB: PDB REMARK 900 5JYN CONTAINS THE TRANSMEMBRANE DOMAIN OF THE SAME PROTEIN REMARK 900 RELATED ID: 6E8W RELATED DB: PDB REMARK 900 6E8W CONTAINS THE MEMBRANE-PROXIMAL EXTERNAL REGION AND THE REMARK 900 TRANSMEMBRANE DOMAIN OF THE SAME PROTEIN REMARK 900 RELATED ID: 30503 RELATED DB: BMRB REMARK 900 RELATED ID: 30678 RELATED DB: BMRB DBREF1 6UJV A 660 788 UNP A0A060KRW4_9HIV1 DBREF2 6UJV A A0A060KRW4 658 786 DBREF1 6UJV B 660 788 UNP A0A060KRW4_9HIV1 DBREF2 6UJV B A0A060KRW4 658 786 DBREF1 6UJV C 660 788 UNP A0A060KRW4_9HIV1 DBREF2 6UJV C A0A060KRW4 658 786 SEQADV 6UJV ARG A 683 UNP A0A060KRW LYS 681 CONFLICT SEQADV 6UJV ILE A 684 UNP A0A060KRW LEU 682 CONFLICT SEQADV 6UJV ILE A 687 UNP A0A060KRW MET 685 CONFLICT SEQADV 6UJV SER A 691 UNP A0A060KRW GLY 689 CONFLICT SEQADV 6UJV LEU A 704 UNP A0A060KRW ILE 702 CONFLICT SEQADV 6UJV THR A 723 UNP A0A060KRW ILE 721 CONFLICT SEQADV 6UJV SER A 764 UNP A0A060KRW CYS 762 ENGINEERED MUTATION SEQADV 6UJV ARG B 683 UNP A0A060KRW LYS 681 CONFLICT SEQADV 6UJV ILE B 684 UNP A0A060KRW LEU 682 CONFLICT SEQADV 6UJV ILE B 687 UNP A0A060KRW MET 685 CONFLICT SEQADV 6UJV SER B 691 UNP A0A060KRW GLY 689 CONFLICT SEQADV 6UJV LEU B 704 UNP A0A060KRW ILE 702 CONFLICT SEQADV 6UJV THR B 723 UNP A0A060KRW ILE 721 CONFLICT SEQADV 6UJV SER B 764 UNP A0A060KRW CYS 762 ENGINEERED MUTATION SEQADV 6UJV ARG C 683 UNP A0A060KRW LYS 681 CONFLICT SEQADV 6UJV ILE C 684 UNP A0A060KRW LEU 682 CONFLICT SEQADV 6UJV ILE C 687 UNP A0A060KRW MET 685 CONFLICT SEQADV 6UJV SER C 691 UNP A0A060KRW GLY 689 CONFLICT SEQADV 6UJV LEU C 704 UNP A0A060KRW ILE 702 CONFLICT SEQADV 6UJV THR C 723 UNP A0A060KRW ILE 721 CONFLICT SEQADV 6UJV SER C 764 UNP A0A060KRW CYS 762 ENGINEERED MUTATION SEQRES 1 A 129 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 A 129 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 A 129 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 A 129 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 A 129 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 A 129 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 A 129 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 A 129 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 A 129 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 A 129 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG SEQRES 1 B 129 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 B 129 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 B 129 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 B 129 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 B 129 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 B 129 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 B 129 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 B 129 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 B 129 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 B 129 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG SEQRES 1 C 129 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 C 129 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 C 129 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 C 129 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 C 129 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 C 129 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 C 129 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 C 129 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 C 129 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 C 129 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG HELIX 1 AA1 GLU A 662 LEU A 669 1 8 HELIX 2 AA2 TRP A 670 TRP A 672 5 3 HELIX 3 AA3 ASP A 674 GLN A 710 1 37 HELIX 4 AA4 ARG A 740 SER A 764 1 25 HELIX 5 AA5 HIS A 769 ARG A 787 1 19 HELIX 6 AA6 GLU B 662 PHE B 673 1 12 HELIX 7 AA7 ASP B 674 ARG B 696 1 23 HELIX 8 AA8 ARG B 696 GLY B 711 1 16 HELIX 9 AA9 ARG B 740 ILE B 746 1 7 HELIX 10 AB1 ARG B 747 SER B 764 1 18 HELIX 11 AB2 TYR B 768 ARG B 787 1 20 HELIX 12 AB3 GLU C 662 PHE C 673 1 12 HELIX 13 AB4 ASP C 674 ARG C 696 1 23 HELIX 14 AB5 ILE C 697 GLY C 711 1 15 HELIX 15 AB6 ARG C 740 ARG C 747 1 8 HELIX 16 AB7 ARG C 747 SER C 764 1 18 HELIX 17 AB8 TYR C 768 ARG C 787 1 20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1